Premium
IL‐10 producing CD8 + CD122 + PD‐1 + regulatory T cells are expanded by dendritic cells silenced for Allograft Inflammatory Factor‐1
Author(s) -
Elizondo Diana M.,
Andargie Temesgen E.,
Haddock Naomi L.,
da Silva Ricardo L. Louzada,
Moura Tatiana Rodrigues,
Lipscomb Michael W.
Publication year - 2019
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1002/jlb.1a0118-010rr
Subject(s) - biology , cytotoxic t cell , microbiology and biotechnology , immune system , t cell , antigen presenting cell , cd8 , dendritic cell , granzyme , immunology , perforin , in vitro , biochemistry
Allograft Inflammatory Factor‐1 (AIF1) is a cytoplasmic scaffold protein that contains Ca 2+ binding EF‐hand and PDZ interaction domains important for mediating intracellular signaling complexes in immune cells. The protein plays a dominant role in both macrophage‐ and dendritic cell (DC)‐mediated inflammatory responses. This study now reports that AIF1 expression in DC is important in directing CD8 + T cell effector responses. Silencing AIF1 expression in murine CD11c + DC suppressed antigen‐specific CD8 + T cell activation, marked by reduced CXCR3, IFNγ and Granzyme B expression, and restrained proliferation. These primed CD8 + T cells had impaired cytotoxic killing of target cells in vitro. In turn, studies identified that AIF1 silencing in DC robustly expanded IL‐10 producing CD8 + CD122 + PD‐1 + regulatory T cells that suppressed neighboring immune effector responses through both IL‐10 and PD‐1‐dependent mechanisms. In vivo studies recapitulated bystander suppression of antigen‐responsive CD4 + T cells by the CD8 + Tregs expanded from the AIF1 silenced DC. These studies further demonstrate that AIF1 expression in DC serves as a potent governor of cognate T cell responses and present a novel target for engineering tolerogenic DC‐based immunotherapies.